Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Jurnal DiMas (Jurnal Pengabdian Kepada Masyarakat) Jurnal Bioteknologi & Biosains Indonesia (JBBI) Jurnal Bioteknologi & Biosains Indonesia
wibowo, sulistiyanto
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Environmental Science Health Professions Medicine & Pharmacology Public Health Other

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Aplikasi Teh Incip Begawat Sebagai Permen Jelly Teh Jahe: The aplication of Begawat "Incip Tea" as Ginger Tea Jelly Candy Anggoro, Aloysius Barry; Purwaningsih, Yuliana; Elisa, Novi; wibowo, sulistiyanto; Pratiwi, Arik Dian Eka; Syukur, Mighfar
Jurnal Dimas Vol 4 No 1 (2022): Jurnal Pengabdian Kepada Masyrakat
Publisher : SEKOLAH TINGGI ILMU FARMASI YAYASAN PHARMASI SEMARANG

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53359/dimas.v4i1.30

Abstract

Teh Incip merupakan hasil perkebunan desa Begawat, Kec. Bumijawa, kabupaten Tegal. Teh Incip adalah teh sangrai secara tradisional yang memiliki aroma yang khas dan rasa sepat khas teh. Inovasi produk teh untuk meningkatkan nilai ekonomisnya. Salah satu inovasi produk dari teh adalah permen jelly. Kombinasi teh Incip dengan jahe menghasilkan permen Jelly teh jahe. Metode pengabdian yang dilakukan dengan cara survei lapangan, rapat koordinasi tim pengabdian dengan mitra, kemudian dilakukan penyuluhan dengan warga yang dilakukan dengan metode ceramah, diskusi, tanya jawab dan pelatihan pembuatan permen teh jahe. Pembuatan permen dilakukan dengan mencampur ekstrak jahe, filtrat teh, gula pasir, agar-agar, jelly, dan sedikit pengawet. Pemanasan campuran ini hingga menjadi caramel dan mengental. Hasilnya dituang dalam cetakan dan dikeringkan pada suhu kamar selama 1 jam, hasil cetakan dipotong sesuai selera dan dikeringanginkan selama 1-2 hari dan siap dikemas. Permen yang dihasilkan berbentuk jelly kenyal dengan rasa jahe. Warga sangat antusias dengan pengabdian yang diberikan. Harapan dari tim pengabdian adalah warga dapat memproduksi permen jelly teh jahe dan dapat memasarkannya sehingga dapat meningkatkan ekonomi warga.
ANALYSIS OF THE RATIONALITY OF ANTIPLATELET USE IN ISCHEMIC STROKE PATIENTS AT “X” HOSPITAL, SEMARANG CITY Wibowo, Sulistiyanto; Dian A, Yustisia; Hasanah A.M, Restu
Jurnal Bioteknologi & Biosains Indonesia (JBBI) Vol. 12 No. 2 (2025)
Publisher : BRIN - Badan Riset dan Inovasi Nasional

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55981/jbbi.2025.11402

Abstract

Ischemic stroke accounts for approximately 85% of all stroke cases and remains a major global health problem. Antiplatelet agents are key for secondary prevention, but irrational use may reduce effectiveness and increase bleeding risk. This retrospective descriptive study evaluated the rationality of antiplatelet use in ischemic stroke patients at “X” Hospital, Semarang City, from January to July 2024. Patients aged ≥26 years with complete medical records were included. Rationality was assessed based on PNPK Stroke Guidelines (2019), AHA/ASA Guidelines (2021), and AHFS Drug Information (2024) using three indicators: appropriate drug, dose, and patient. A total of 111 patients (113 cases) met the inclusion criteria. Most were male (58.56%) and aged >65 years (36.04%), with hypertension, diabetes, and hyperlipidemia as common comorbidities. Aspirin was the most used monotherapy (38.05%), and aspirin–clopidogrel the most frequent combination (37.17%). Drug selection accuracy was high (96.46%), while dose accuracy was low (44.25%). Antiplatelet use at “X” Hospital demonstrated rational drug selection but suboptimal dosing. Improved adherence to dosing guidelines and periodic prescription review are needed to enhance patient safety and treatment outcomes.
ANALYSIS OF THE RATIONALITY OF ANTIPLATELET USE IN ISCHEMIC STROKE PATIENTS AT “X” HOSPITAL, SEMARANG CITY Wibowo, Sulistiyanto; Dian A, Yustisia; Hasanah A.M, Restu
Jurnal Bioteknologi & Biosains Indonesia (JBBI) Vol. 12 No. 2 (2025)
Publisher : BRIN - Badan Riset dan Inovasi Nasional

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55981/jbbi.2025.11402

Abstract

Ischemic stroke accounts for approximately 85% of all stroke cases and remains a major global health problem. Antiplatelet agents are key for secondary prevention, but irrational use may reduce effectiveness and increase bleeding risk. This retrospective descriptive study evaluated the rationality of antiplatelet use in ischemic stroke patients at “X” Hospital, Semarang City, from January to July 2024. Patients aged ≥26 years with complete medical records were included. Rationality was assessed based on PNPK Stroke Guidelines (2019), AHA/ASA Guidelines (2021), and AHFS Drug Information (2024) using three indicators: appropriate drug, dose, and patient. A total of 111 patients (113 cases) met the inclusion criteria. Most were male (58.56%) and aged >65 years (36.04%), with hypertension, diabetes, and hyperlipidemia as common comorbidities. Aspirin was the most used monotherapy (38.05%), and aspirin–clopidogrel the most frequent combination (37.17%). Drug selection accuracy was high (96.46%), while dose accuracy was low (44.25%). Antiplatelet use at “X” Hospital demonstrated rational drug selection but suboptimal dosing. Improved adherence to dosing guidelines and periodic prescription review are needed to enhance patient safety and treatment outcomes.
Co-Authors Anggoro, Aloysius Barry Dian A, Yustisia Elisa, Novi Hasanah A.M, Restu Pratiwi, Arik Dian Eka Purwaningsih, Yuliana Syukur, Mighfar